Skip to main content

EVEROLIMUS TABLETS COST IN INDIA

EVEROLIMUS

DESCRIPTION 


Everolimus belongs to the anti-neoplastic agent; it comes under mTOR kinase inhibitor (single transduction inhibitor). Everolimus is an immunosuppressive macrolide.

EVEROLIMUS USED FOR


Breast cancer 

The patient who fails to respond to the tablet letrozole or anastrozole therapy would be treated with Everolimus. Everolimus is used in the advanced stage of breast cancer.

Neuroendocrine tumors 

Everolimus involved in the treatment of some neuroendocrine tumors like pancreatic, gastrointestinal or lung cancer.

Renal cell cancer

Patient treating with Everolimus after the failure of treatment with Sunitinib or Sorafenib. Everolimus also used in the condition of Heart, liver, kidney transplantation, Waldenstrom macroglobulinemia, Other carcinoid tumors


Brand: Evertor


Strength: 10mg


Ingredient: Everolimus


Company Name: Biocon


Tab Count: 10 Tablets


MECHANISM OF ACTION


Everolimus is the prohibition of mammalian target of rapamycin (mTOR), a serine-threonine kinase. Everolimus bind with intercellular protein (FKBP-12), leads to inhibitory complex formation with mTOR complex 1 (mTORC1) this leads to inhibition of mTOR kinase activity. 

Everolimus decreased the effect of S6 ribosomal protein kinase (S6K1) and eukaryotic elongation factor 4E binding protein (4E-BP1) which are essential for protein synthesis. mTOR inhibited by Everolimus lead to reduce cell multiplication and angiogenesis.

DOSAGE AND ADMINISTRATION OF EVEROLIMUS


The recommended dose of the Tablet Everolimus is 5mg, 10mg should be taken as a single dose in all carcinogenic condition, except organ transplantation.

OVERDOSAGE


The over dosage of Everolimus is rarely occur, in the case of overdosage, the patient must be provided with supportive measures. The acute toxicity of Everolimus overdosage should be monitored.


EVEROLIMUS SIDE EFFECTS


The side effects of Everolimus tablets are predicted by the terms of their onset, duration, and severity Side effects of Everolimus is preventable and it is minimized Mouth sores, Mucositis, Stomatitis or esophagitis, Infection, Rash, itching or dry skin, Fatigue, Diarrhea, Edema, Stomach pain, Nausea, vomiting, Fever, Weakness or asthenia, Headache.

PREGNANCY


Everolimus should not use in pregnancy conditions and for breastfeeding mothers. Pregnancy category: C Everolimus causes harm or any malformation in unborn babies.

STORAGE


Everolimus should be stored in room temperature Keep away from moisture, heat, and light.


MISSED DOSE


In case of a missed dose, patients must consult with a medical practitioner and follow the instructions given by them. On the other hand, the missed dose should be avoided and follow the regular dosing schedule.


FOR MORE INFORMATION:



EMAIL:


info@blueberrypharma.com


PHONE:


+91-97890 77748


VISIT US:




Labels:

Comments

  1. James BerrySeptember 17, 2019 at 11:38 PM

    https:httThank you for sharing in this information. It is very useful for Cancer Patients
    Everolimus Tablets Price

    ReplyDelete

Post a Comment

Popular posts from this blog

Nivolumab (Opdivo & Opdyta) Injection Online | Blueberry pharmaceuticals

NIVOLUMAB Nivolumab belongs to a group of cancer drugs known as monoclonal antibodies. Nivolumab is also known as an immune checkpoint inhibitor. Sometimes these drugs are called targeted therapies because they target specific proteins (receptors) on the surface of cells. Nivolumab is a prescription drug which is used under the supervision of a doctor INDICATION Nivolumab is indicated for the treatment of patients having Melanoma. Nivolumab is indicated for the treatment of patients having Non-Small Cell Lung Cancer. Nivolumab is indicated for the treatment of patients having Kidney (Renal Cell) Cancer. MECHANISM OF ACTION Nivolumab prohibits the molecule activity called PD-1, and it is a protein which prevents T cells from recognizing and attacking inflamed tissues and cancer cells. PD-1 can deceit the immune system into overlooking melanoma cells as normal cells. DOSAGE AND ADMINISTRATION Nivolumab recommended dosage for unresectable or metastatic melanoma : As a single
Post a Comment
Read more

Evertor 5 mg | Everolimus | Blueberry pharmaceuticals

EVERTOR 5MG Evertor 5mg belongs to the anti-neoplastic agent; it comes under mTOR kinase inhibitor (single transduction inhibitor). Evertor 5mg is an immunosuppressive macrolide. EVERTOR USED FOR Breast cancer  The patient who failed to respond to the tablet letrozole or anastrozole therapy, would be treated with Evertor. Evertor 5mg is used in an advanced stage of breast cancer. Neuroendocrine tumors  Evertor 5mg involved in the treatment of some neuroendocrine tumors like pancreatic, gastrointestinal or lung cancer. Renal cell cancer  patient treating with Evertor 5mg after the failure of treatment with Sunitinib or Sorafenib. Evertor also used in the condition of: Heart, liver, kidney transplantation Waldenstrom macroglobulinemia Other carcinoid tumors MECHANISM OF ACTION Evertor is prohibitor of mammalian target of rapamycin (mTOR), a serine threonine kinase. Evertor bind with intercellular protein (FKBP-12), leads to inhibitory complex formation with mTOR comple
Post a Comment
Read more